Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies Vaccine (Vero cell) 4-dose vs 5-dose Post-exposure Schedules Safety and Compliance Study
CTR20222797Phase 4Completed
- Sponsor
- Changchun Institute of Biological Products Co., Ltd.
- Start
- Nov 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Rabies Vaccine (Serum-free Vero Cell) in rabies, sponsored by Changchun Institute of Biological Products Co., Ltd.. Started Nov 2022; status: completed.
02
Drugs
Rabies Vaccine (Serum-free Vero Cell)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20222797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222797.